【醫(yī)學(xué)課件】充血性心力衰竭ppt課件-資料下載頁
2025-01-15 20:47本頁面
【正文】 IHD, Dilated CMP, corrected valve disease or regurgitant valve disease deemed uncorrectable due to severe LV dysfunction, hypertension, or hypertrophic disease of the elderly ? LVEF within 6 months showing nonsystolic HF ? Patient care provided by a physician other than a SPAN CHF provider Patient Characteristics Intervention (n=97) Control (n=103) P Age (mean + SD) + + Female Gender, % NS Ischemic CMP, % NS Hypertension, % NS Diabetes NS EF mean + 14 + 12 NS Medications, % NS ACE ARB ACE or ARB Bblocker Diuretics Days 180 150 120 90 60 30 0 Cumulative Event Free Survival .9 .8 .7 .6 .5 Treatment intervention control SPANCHF: EVENT FREE SURVIVAL SPANCHF: HF Hospitalizations, Hospital Days / PatientYear Alive in Initial 90 Days 1. 140. 557. 84. 3012345678H os p i ta l i z a ti on s H os p i ta l D a y sC on tr olI n te r v e n ti onRR= P= RR= P SPANCHF: HF Hospitalizations, Hospital Days / PatientYear Alive 1 Year 0. 73 0. 744. 94. 300. 511. 522. 533. 544. 55H os p i ta l i z a ti on s H os p i ta l D a y sC on tr olI n te r v e n ti onRR= P= RR= P CONCLUSIONS ? CHF is a devastating result of cardiovascular disease which continues to increase ? Multiple effective strategies are available to deal with this epidemic but not routinely delivered to patients ? Disease management strategies result in cost effective improvement in patients outes. Spread ? To other parts of the hospital ? To other hospitals in the system ? To other settings in the care continuum – Home Care – Office – HF Clinic When to Spread? ? There is intent to spread work of the pilot team in the anization ? Improvement is a key initiative for the anization ? Senior leader is responsible and engaged in coordination and spread of innovation ? Collaborative team is relatively selfsufficient
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號(hào)-1